Recent advances in pharmacogenetics can help identify individual genetic variations which may explain the differences in the response of subjects to drugs in clinical trials. In response to this growing need, Ambry Genetics offers our Drug Rescue Program. The program aims to identify the underlying genetic causes of the adverse events. Once the genetic cause is determined, a subset of clinical trial participants can be identified and the trial can resume.